Literature DB >> 15660230

Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia.

Toshimi Michigami1, Takayuki Uchihashi, Akira Suzuki, Kanako Tachikawa, Shigeo Nakajima, Keiichi Ozono.   

Abstract

UNLABELLED: A total of 22 Japanese patients with hypophosphatasia were included in a study analysing the relationship between mutations in the tissue-nonspecific alkaline phosphatase (TNSALP) gene and the severity of the phenotype in Japanese patients with hypophosphatasia. The enzymatic activity of some of the identified mutant TNSALP proteins was also examined using corresponding expression vectors. Eighteen mutations, including 6 novel ones, were identified in the patients. Among them, the common mutations were F310L and T1559del. Of note, five patients with F310L mutation in one of the alleles exhibited a relatively mild phenotype without respiratory complications despite its perinatal onset. In contrast, the T1559del mutation is associated with perinatal lethal and infantile forms when not found in patients with the F310L mutation. The genotype-phenotype relationship was, to some extent, consistent with the enzymatic activity of the mutant ALP proteins; mutations K207E and G409C found in a surviving case of infantile hypophosphatasia, as well as F310L, retained some residual activities, whereas T1559del caused a complete loss of activity.
CONCLUSION: In Japanese patients, the common mutations F310L and T1559del are associated with the relatively mild and lethal forms of hypophosphatasia, respectively. Our results may enhance the importance of genotyping patients with hypophosphatasia to predict their prognosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15660230     DOI: 10.1007/s00431-004-1612-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  Mild hypophosphatasia mimicking severe osteogenesis imperfecta in utero: bent but not broken.

Authors:  R M Pauli; P Modaff; S L Sipes; M P Whyte
Journal:  Am J Med Genet       Date:  1999-10-29

2.  The quantitative histochemistry of brain. II. Enzyme measurements.

Authors:  O H LOWRY; N R ROBERTS; M L WU; W S HIXON; E J CRAWFORD
Journal:  J Biol Chem       Date:  1954-03       Impact factor: 5.157

3.  Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group.

Authors:  S E Antonarakis
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  Mild autosomal dominant hypophosphatasia: in utero presentation in two families.

Authors:  C A Moore; C J Curry; P S Henthorn; J A Smith; J C Smith; P O'Lague; S P Coburn; D D Weaver; M P Whyte
Journal:  Am J Med Genet       Date:  1999-10-29

5.  Characterization of eleven novel mutations (M45L, R119H, 544delG, G145V, H154Y, C184Y, D289V, 862+5A, 1172delC, R411X, E459K) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in patients with severe hypophosphatasia. Mutations in brief no. 217. Online.

Authors:  A Taillandier; L Zurutuza; F Muller; B Simon-Bouy; J L Serre; L Bird; R Brenner; O Boute; J Cousin; D Gaillard; P H Heidemann; B Steinmann; M Wallot; E Mornet
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

6.  Novel missense and frameshift mutations in the tissue-nonspecific alkaline phosphatase gene in a Japanese patient with hypophosphatasia.

Authors:  H Orimo; Z Hayashi; A Watanabe; T Hirayama; T Hirayama; T Shimada
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

7.  Infantile hypophosphatasia: treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization.

Authors:  J P Barcia; C F Strife; C B Langman
Journal:  J Pediatr       Date:  1997-05       Impact factor: 4.406

8.  Asp361Val Mutant of alkaline phosphatase found in patients with dominantly inherited hypophosphatasia inhibits the activity of the wild-type enzyme.

Authors:  H L Müller; M Yamazaki; T Michigami; T Kageyama; E Schönau; P Schneider; K Ozono
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

9.  Evidence of a founder effect for the tissue-nonspecific alkaline phosphatase (TNSALP) gene E174K mutation in hypophosphatasia patients.

Authors:  Muriel Hérasse; Marc Spentchian; Agnès Taillandier; Etienne Mornet
Journal:  Eur J Hum Genet       Date:  2002-10       Impact factor: 4.246

Review 10.  Missense mutations of the tissue-nonspecific alkaline phosphatase gene in hypophosphatasia.

Authors:  P S Henthorn; M P Whyte
Journal:  Clin Chem       Date:  1992-12       Impact factor: 8.327

View more
  23 in total

1.  Novel heterozygous tissue-nonspecific alkaline phosphatase (TNAP) gene mutations causing lethal perinatal hypophosphatasia.

Authors:  Kai-Chi Chang; Po-Han Lin; Yi-Ning Su; Steven Shinn-Forng Peng; Ni-Chung Lee; Hung-Chieh Chou; Chien-Yi Chen; Wu-Shiun Hsieh; Po-Nien Tsao
Journal:  J Bone Miner Metab       Date:  2011-06-04       Impact factor: 2.626

2.  Adult hypophosphatasia with painful periarticular calcification treated with surgical resection.

Authors:  Kei-Ichiro Iida; Jun-Ichi Fukushi; Toshifumi Fujiwara; Yoshinao Oda; Yukihide Iwamoto
Journal:  J Bone Miner Metab       Date:  2011-12-15       Impact factor: 2.626

3.  Molecular diagnosis of hypophosphatasia and differential diagnosis by targeted Next Generation Sequencing.

Authors:  Agnès Taillandier; Christelle Domingues; Clémence De Cazanove; Valérie Porquet-Bordes; Sophie Monnot; Tina Kiffer-Moreira; Agnès Rothenbuhler; Pascal Guggenbuhl; Catherine Cormier; Geneviève Baujat; Françoise Debiais; Yline Capri; Martine Cohen-Solal; Philippe Parent; Jean Chiesa; Anne Dieux; Florence Petit; Joelle Roume; Monica Isnard; Valérie Cormier-Daire; Agnès Linglart; José Luis Millán; Jean-Pierre Salles; Christine Muti; Brigitte Simon-Bouy; Etienne Mornet
Journal:  Mol Genet Metab       Date:  2015-09-30       Impact factor: 4.797

Review 4.  Dental manifestation and management of hypophosphatasia.

Authors:  Rena Okawa; Kazuhiko Nakano
Journal:  Jpn Dent Sci Rev       Date:  2022-07-02

5.  Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.

Authors:  Michael P Whyte; Cheryl Rockman-Greenberg; Keiichi Ozono; Richard Riese; Scott Moseley; Agustin Melian; David D Thompson; Nicholas Bishop; Christine Hofmann
Journal:  J Clin Endocrinol Metab       Date:  2015-11-03       Impact factor: 5.958

6.  Benign prenatal hypophosphatasia: a treatable disease not to be missed.

Authors:  Masaki Matsushita; Hiroshi Kitoh; Toshimi Michigami; Kanako Tachikawa; Naoki Ishiguro
Journal:  Pediatr Radiol       Date:  2013-10-22

7.  Autosomal recessive hypophosphatasia manifesting in utero with long bone deformity but showing spontaneous postnatal improvement.

Authors:  David A Stevenson; John C Carey; Stephen P Coburn; Karen L Ericson; Janice L B Byrne; Steven Mumm; Michael P Whyte
Journal:  J Clin Endocrinol Metab       Date:  2008-06-17       Impact factor: 5.958

8.  A Case of Vitamin D Deficiency without Elevation of Serum Alkaline Phosphatase in a Carrier of Hypophosphatasia.

Authors:  Kumihiro Matsuo; Tokuo Mukai; Akiko Furuya; Shigeru Suzuki; Yusuke Tanahashi; Hiroshi Azuma
Journal:  Clin Pediatr Endocrinol       Date:  2013-10-26

Review 9.  Pathophysiology of hypophosphatasia and the potential role of asfotase alfa.

Authors:  Hideo Orimo
Journal:  Ther Clin Risk Manag       Date:  2016-05-17       Impact factor: 2.423

10.  Clinical characteristics of perinatal lethal hypophosphatasia: a report of 6 cases.

Authors:  Akari Nakamura-Utsunomiya; Satoshi Okada; Keiichi Hara; Shinichiro Miyagawa; Kanae Takeda; Rie Fukuhara; Yusei Nakata; Michiko Hayashidani; Kanako Tachikawa; Toshimi Michigami; Keiichi Ozono; Masao Kobayashi
Journal:  Clin Pediatr Endocrinol       Date:  2010-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.